{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:49:18Z","timestamp":1781142558075,"version":"3.54.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PROM"],"DOI":"10.2147\/prom.s52788","type":"journal-article","created":{"date-parts":[[2014,7,6]],"date-time":"2014-07-06T19:12:13Z","timestamp":1404673933000},"page":"63","source":"Crossref","is-referenced-by-count":13,"title":["Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes"],"prefix":"10.1080","author":[{"given":"Siamak","family":"Daneshmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,7]]},"container-title":["Patient Related Outcome Measures"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=20710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:24:40Z","timestamp":1780352680000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/androgen-deprivation-therapy-for-prostate-cancer-long-term-safety-and--peer-reviewed-article-PROM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/prom.s52788","relation":{},"ISSN":["1179-271X"],"issn-type":[{"value":"1179-271X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}